Hunter Perkins Capital Management’s Nuvation Bio NUVB Stock Holding History

Hunter Perkins Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,200	Closed	-$91K	–	150
2025 Q4	$91K	Sell	10,200 -12,300	-55%	-$76.2K	0.02%	113
2025 Q3	$83K	Hold	22,500	–	–	0.02%	114
2025 Q2	$44K	Hold	22,500	–	–	0.01%	108
2025 Q1	$40K	Hold	22,500	–	–	0.01%	102
2024 Q4	$60K	Hold	22,500	–	–	0.01%	102
2024 Q3	$52K	Hold	22,500	–	–	0.01%	104
2024 Q2	$66K	Sell	22,500 -500	-2%	-$1.53K	0.01%	105
2024 Q1	$84K	Hold	23,000	–	–	0.02%	104
2023 Q4	$35K	Hold	23,000	–	–	0.01%	88
2023 Q3	$31K	Hold	23,000	–	–	0.01%	125
2023 Q2	$41K	Hold	23,000	–	–	0.01%	122
2023 Q1	$38K	Hold	23,000	–	–	0.01%	112
2022 Q4	$44K	Buy	23,000 +8,500	+59%	+$17.2K	0.01%	93
2022 Q3	$32K	Hold	14,500	–	–	0.01%	88
2022 Q2	$47K	Hold	14,500	–	–	0.01%	83
2022 Q1	$76K	Hold	14,500	–	–	0.02%	83
2021 Q4	$123K	Sell	14,500 -2,000	-12%	-$18.4K	0.02%	86
2021 Q3	$164K	Hold	16,500	–	–	0.03%	76
2021 Q2	$154K	Sell	16,500 -2,500	-13%	-$28.5K	0.03%	85
2021 Q1	$199K	Sell	19,000 -7,500	-28%	-$83.9K	0.04%	82
2020 Q4	$310K	Buy	+26,500	New	+$276K	0.05%	143

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hunter Perkins Capital Management's NUVB Position: Q1 2026 in Review

Hunter Perkins Capital Management sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 10,200 shares — an estimated $91K sold.

Hunter Perkins Capital Management first reported a position in NUVB in Q4 2020 and held it in 21 quarters. The position peaked at $310K in Q4 2020. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

Hunter Perkins Capital Management reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
Hunter Perkins Capital Management sold 10,200 Nuvation Bio shares in Q1 2026, an estimated $91K.
Hunter Perkins Capital Management first reported a position in Nuvation Bio in Q4 2020 and held it in 21 quarters.
Hunter Perkins Capital Management's Nuvation Bio position peaked at $310K in Q4 2020.
231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2026, filed 12 May 2026.